XML 86 R60.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Equity Instruments (Details Textual) - USD ($) | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | ---
May 31, 2018 | Mar. 31, 2018 | Jan. 31, 2018 | Nov. 30, 2017 | Sep. 30, 2017 | Aug. 31, 2017 | Feb. 28, 2017 | Nov. 30, 2016 | Oct. 31, 2016 | May 31, 2016 | Mar. 31, 2018 | Dec. 31, 2017 | Jun. 30, 2018 | Jun. 30, 2017 | Jun. 01, 2015
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecognized expense share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 161,000 |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | 348,515 | $ 2,502,092 |
Unrecognized share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 2,945,000 |  |
Weighted-average period |  |  |  |  |  |  |  |  |  |  |  |  | 8 years 7 months 17 days |  |
Expense related to awards |  |  |  |  |  |  |  |  |  |  |  |  | $ 139,000 |  |
New warrant to purchase shares |  |  |  |  |  |  |  |  |  |  |  |  | 100,000 |  |
Equity fair value |  |  |  |  |  |  |  | $ 4,200,000 |  |  |  |  | $ 179,000 |  |
Restricted stock for accelerated vesting |  |  |  |  |  |  |  |  |  |  |  |  | 2,000 |  |
Exercise price |  |  |  |  |  |  | $ 300.00 |  |  |  |  |  |  |  |
May 2016 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  | $ 2,400.00 |  |  |  |  |  |  |  |
Aggregate shares of common stock |  |  |  |  |  |  | 4,334 |  |  |  |  |  |  |  |
October 2016 Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  |  |  |  |  |  | 7,477 |  |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  | $ 744 |  |  |  |  |  |  |  |
Aggregate shares of common stock |  |  |  |  |  |  | 15,051 |  |  |  |  |  |  |  |
Proceeds from issuance of warrant |  |  |  |  |  |  | $ 2,200,000 |  |  |  |  |  |  |  |
Restricted Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price |  |  |  |  |  |  |  |  |  |  |  |  | $ 39.80 |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 14,000 |  |
IPO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecognized expense, shares |  |  |  |  |  |  |  | 14,338 |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  |  |  |  |  |  |  |  | 5,750 |  |
November 2016 Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  |  |  |  |  |  |  |  |  |  |  |  | 1,009 |  |
Warrants exercise price |  |  |  |  |  |  |  |  |  |  |  |  | $ 744.00 |  |
Warrants exercise price term |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |
November 2016 Public Offering One [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  |  |  |  |  |  |  |  |  |  |  |  | 15,051 |  |
Warrants exercise price |  |  |  |  |  |  |  |  |  |  |  |  | $ 744.00 |  |
Warrants exercise price term |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |
Aytu Bioscience Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  | 75,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price |  | $ 72.00 |  |  |  |  |  |  |  |  |  |  |  |  |
Aytu Bioscience Inc [Member] | Restricted Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock, Shares |  |  |  |  |  |  |  |  |  |  | 200 |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  | $ 37,000 |  |  |  |
Executive Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecognized expense, shares |  |  |  |  |  |  |  |  |  |  |  |  | 4,167 |  |
2015 Stock Option and Incentive Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate shares of common stock |  |  |  |  |  |  |  |  |  |  |  |  | 3,000,000 |  | 3,000,000
Unrecognized expense share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,593,000 |  |
Grant purchase |  |  |  |  |  |  |  |  |  |  |  |  | 2,961,055 |  |
Restricted stock, Shares |  |  | 3,750 | 150 | 10,000 |  |  |  |  |  | 650 | 413 | 1,538 |  |
Vesting expiry date |  |  |  |  |  |  |  |  |  |  |  |  | 10 years |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  |  | $ 36,000 |  |  |
Vesting expiry date, description |  |  | January 2028 |  | September 2027 |  |  |  |  |  |  |  | July 2026 |  |
2015 Stock Option and Incentive Plan [Member] | Aytu Bioscience Inc [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock, Shares |  |  |  |  |  |  |  |  |  |  | 23,000 |  |  |  |
Stock-based compensation expense |  |  |  |  |  |  |  |  |  |  | $ 74,000 |  |  |  |
2015 Stock Option and Incentive Plan [Member] | Executive Officer Director And Consultants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock, Shares |  |  |  | 24,750 |  |  |  |  |  |  |  |  |  |  |
Vesting expiry date, description |  |  |  | November 2027 |  |  |  |  |  |  |  |  |  |  |
2015 Plan [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock, Shares |  | 650 |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting expiry date, description |  | March 2028 |  |  |  |  |  |  |  |  |  |  |  |  |
2015 Plan [Member] | Officer [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted stock, Shares |  |  | 3,750 |  |  |  |  |  |  |  |  |  |  |  |
Vesting expiry date, description |  |  | January 2028 |  |  |  |  |  |  |  |  |  |  |  |
Common Stock [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  |  |  |  |  |  |  |  |  |  |  |  | 80,750 |  |
Equity fair value |  |  |  |  |  |  |  | $ 4,400,000 |  |  |  |  |  |  |
Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  |  |  |  |  | 315,755 |  |  |  |  |  |  |  | 221 |
Warrants exercise price | $ 21,744.00 | $ 10.80 |  |  |  | $ 72.00 | $ 300.00 |  | $ 744.00 | $ 2,400.00 |  |  |  | $ 1,600.00 |
Warrants exercise price term | 5 years |  |  |  |  | 5 years |  |  |  |  |  |  |  | 5 years |
Warrants generated non-cash expense |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 596,000 |
Net proceeds |  | $ 615,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Unrecognized share-based compensation expense |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,288 |  |
Equity fair value |  |  |  |  |  |  |  | $ 293,000 |  |  |  |  |  |  |
Exercise price |  |  |  |  |  |  |  | $ 744.00 |  |  |  |  |  |  |
Proceeds from issuance of warrant |  |  |  |  |  |  |  | $ 7,300,000 |  |  |  |  |  |  |
Incremental fair value of warrant |  |  |  |  |  |  | $ 178,000 |  |  |  |  |  | $ 23,000 |  |
Warrant [Member] | IPO [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Instruments (Textual) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase of common stock |  | 1,533,356 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price |  | $ 10.80 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise price term |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  | 1,533,356 |  |  |  |  |  |  |  |  | 1,533,356 |  |  |  |

X
- References No definition available. + Details
Name: | aytu_EquityInstrumentsTextualAbstract
Namespace Prefix: | aytu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of incremental fair value of warrant. + References No definition available. + Details
Name: | aytu_IncrementalFairValueOfWarrant
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition New Warrants to purchase of common stock. + References No definition available. + Details
Name: | aytu_NewWarrantsToPurchaseOfCommonStock
Namespace Prefix: | aytu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition vesting expiry date. + References No definition available. + Details
Name: | aytu_VestingExpiryDate
Namespace Prefix: | aytu_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrants exercise price term. + References No definition available. + Details
Name: | aytu_WarrantsExercisePriceTerm
Namespace Prefix: | aytu_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of warrants generated a non-cash expense. + References No definition available. + Details
Name: | aytu_WarrantsGeneratedNoncashExpense
Namespace Prefix: | aytu_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of warrants to purchase of common stock. + References No definition available. + Details
Name: | aytu_WarrantsToPurchaseOfCommonStockShares
Namespace Prefix: | aytu_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(4)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Unrecognized cost of unvested share-based compensation awards. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Weighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Unrecognized cost of unvested options awarded to employees as compensation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of the entity's equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258 + Details
Name: | us-gaap_EquityFairValueDisclosure
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromDebtNetOfIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585 + Details
Name: | us-gaap_ProceedsFromIssuanceOfWarrants
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 + Details
Name: | us-gaap_ShareBasedCompensation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix: | us-gaap_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901 + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Gross number of share options (or share units) granted during the period. + References No definition available. + Details
Name: | us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares for which recognition of compensation cost was accelerated. + References No definition available. + Details
Name: | us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The noncash expense that accounts for the value of stock or unit options distributed to employees as compensation. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585 + Details
Name: | us-gaap_StockOptionPlanExpense
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=aytu_MayTwoZeroOneSixWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=aytu_OctoberTwoZeroOneSixWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=aytu_NovemberTwoThousandSixTeenPublicOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=aytu_NovemberTwoThousandSixTeenPublicOfferingOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=aytu_AytuBioscienceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=us-gaap_ExecutiveOfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=aytu_TwoThousandFifteenStockOptionAndIncentivePlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=aytu_ExecutiveOfficerDirectorAndConsultantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_PlanNameAxis=aytu_TwoThousandFifteenPlanMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TitleOfIndividualAxis=us-gaap_OfficerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |